PORT ST LUCIE, FL, September 18, 2026 /24-7PressRelease/ -- Margarette Jean-Francois has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Ms. Jean-Francois has established herself as an expert in project and program management within pharmaceutical scientific, operational, quality and regulatory environments. Her career reflects a steady progression through increasingly responsible roles, each contributing to her reputation for leading complex initiatives to successful completion.

Since 2026, Ms. Jean-Francois has served as strategic PMO leader specializing in AI change management and process improvement at Jfmconsulting2 Inc. In this capacity, she evaluates client companies' business processes to identify operational bottlenecks, develops standard operating procedures for small companies and startups, builds AI agents to automate portions of client workflows and advises organizations on improving their internal processes. This role marks the culmination of her decades-long commitment to advancing operational excellence in the pharmaceutical and life sciences sectors.

From 2024 to 2026, Ms. Jean-Francois served as a senior global project manager at Pharmaron. She spearheaded the company-wide process improvement initiative for Standard Operating Procedures (SOPs), driving strategic enhancements to strengthen operational efficiency, consistency, and compliance. She also led training initiatives for the Project Management and Clinical Research Associates teams, advancing organizational capabilities and reinforcing adherence to quality standards. In addition, she directed the remediation of audit findings and led SOP compliance alignment efforts, strengthening the company's overall compliance framework and readiness for regulatory and quality oversight. She continued to demonstrate her ability to manage large-scale projects across multiple countries and sites with teams of up to 30 people.

Among her proudest achievements is leading the Food and Drug Administration approval project for the drug Eylea, for Regeneron Pharmaceuticals, during which her team passed an inspection with no findings—a testament to her leadership and attention to detail. There she also developed a Process document in preparation of the FDA audit which led to the successful outcome.

From 2020 to 2023, Ms. Jean-Francois held the position of senior global project manager at Eli Lilly, where she further honed her skills in overseeing international clinical research initiatives. Her tenure at Eli managing multifaceted programs that required coordination among diverse stakeholders in multiple countries.

Between 2019 and 2022, she contributed as a senior global clinical study manager at Pfizer, leveraging her expertise in clinical trial oversight. Prior to this, she was a senior clinical project manager at Translational Drug Development from 2018 to 2019, where she managed critical projects supporting drug development pipelines.

Her earlier experience includes serving as a clinical trial manager at Quintiles from 2016 to 2018 and as a senior clinical research associate at ICON plc from 2015 to 2016. She also held the role of senior clinical trial manager at Regenesis Biomedical Inc. between 2012 and 2015 and at Regeneron Pharmaceuticals Inc. from 2009 to 2012. From 2008 to 2009, Ms. Jean-Francois worked as a senior clinical study manager at Pfizer.

Her foundational years in the industry included positions as a clinical study monitor at Roche (2005-2008), a clinical research associate at Sumitomo Pharmaceuticals (2003-2005), and a clinical research associate at Covance (2001-2003). Before entering the pharmaceutical sector, she supported academic operations as an education program coordinator for Montclair State University from 1990 to 2000.

Ms. Jean-Francois's educational background has been instrumental in shaping her professional journey. She earned a Master of Business Administration in health care administration and management from American InterContinental University in Chicago in 2007. Her undergraduate studies culminated in a Bachelor of Science in public health education and promotion from Montclair State University in Montclair in 2002. She completed certificate in AI Agentic Process Improvement at MIT. She is also continuing to upgrade her Six Sigma training. These academic achievements provided a strong foundation for her work in health care project management and organizational leadership.

She spearheaded the company-wide process improvement initiative for Standard Operating Procedures (SOPs), driving strategic enhancements to strengthen operational efficiency, consistency, and compliance. She also led training initiatives for the Project Management and Clinical Research Associates teams, advancing organizational capabilities and reinforcing adherence to quality standards. In addition, she directed the remediation of audit findings and led SOP compliance alignment efforts, strengthening the company's overall compliance framework and readiness for regulatory and quality oversight.

Persistence, unwavering effort and a commitment to excellence have been central themes throughout Ms. Jean-Francois's career. She attributes her success to these qualities, which have enabled her not only to complete challenging assignments but also to deliver results that exceed expectations.

Born in the Caribbean, Ms. Jean-Francois is deeply connected to her heritage while embracing cultural exploration through travel. She has visited destinations including Portugal, Greece, Colombia, Panama, Costa Rica, Ghana, Benin, Gabon and both the Eastern and Western Caribbean islands. Her passion for personal growth extends beyond travel; she enjoys visiting museums and gardening, with a particular interest in growing herbs. Family is a source of pride for Ms. Jean-Francois. She is the mother of two adult daughters: one who has followed her path into project management and another who works as a realtor and is recently married. She is also a grandmother to a granddaughter currently attending high school.

Previously active in volunteer work, Ms. Jean-Francois has stepped back due to career demands but is seeking new charitable opportunities with a special interest in supporting women's shelters. Looking ahead, she intends to build her consulting agency into a thriving enterprise focused on helping small companies establish robust operations.

Ms. Jean-Francois's enduring dedication to professional growth, cultural understanding and community engagement continues to define her legacy within the field of pharmaceutical project management and beyond.

# # #